Jun 27, 2023 8:05am EDT Ensysce Biosciences and Quotient Sciences to Present MPAR(R) Overdose Protection Platform at Upcoming CRS 2023 Annual Meeting and Expo
Jun 07, 2023 9:55am EDT Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website
May 09, 2023 8:00am EDT Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
Apr 19, 2023 9:25am EDT Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development